Evaluation Of COVID Drugs Management in Pharmaceutical Installations Of Royal Prima Hospital Medan During the COVID-19 Pandemic
DOI:
https://doi.org/10.59141/jrssem.v1i7.104Keywords:
COVID drug management, COVID -19, pharmacyAbstract
Coronavirus Disease 2019 (COVID-19) has been declared by WHO as a global pandemic and in Indonesia it is declared as a type of disease that causes public health emergencies and non-natural disasters, which is not only causing death but also cause significant economic losses, so it is necessary to take steps to overcome it including prevention and control. This study aimed to analyze the evaluation of the handling of Covid drugs at the Pharmacy Installation of the Royal Prima Hospital in Medan during the COVID-19 Pandemic. This study used qualitative research located at the Pharmacy Installation of RSU Royal Prima Medan during the COVID-19 Pandemic. While The population in this study were 5 informants consisting of the Director of Medical Services, Head of Pharmacy Installation at Royal Prima Hospital Medan, Head of Pharmacy Warehouse, Pharmacist, and Assistant Pharmacist. In this study, the techniques used in data collection methods were Direct Observation, In-Depth Interviews, and Document Literature. The data analysis method was carried out by compiling, discussing, and evaluating the data and the results of interviews/observations using the Triangulation Test. Based on results studies, this state has carried out the process of procurement, receipt, storage, and distribution in the evaluation management drug covid on installation Pharmacy at Hospital Royal Prima Medan during the COVID-19 pandemic with supported with existence existing facilities and infrastructure and the number of available human resources at Hospital Royal Prima Medan.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Dicca Brentazzoly Br Tarigan, Chrismis N. Ginting, Sri Lestari Ramadhani Nasution
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.